LYCA · Forms 3, 4, 5
Insider trades at Lycia Therapeutics
1 insider bought $38.3M of Lycia Therapeutics stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Lycia Therapeutics (LYCA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 8,804 | $26.27 | $231K | Form 4 | |
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 200 | $26.86 | $5K | Form 4 | |
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 1,000 | $26.33 | $26K | Form 4 | |
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 10,570 | $25.23 | $267K | Form 4 | |
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 4,430 | $25.97 | $115K | Form 4 | |
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 8,729 | $25.84 | $226K | Form 4 | |
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 31,067 | $26.84 | $834K | Form 4 | |
| Versant Ventures VII GP, L.P. | 10% owner | Conversion | 5,631,425 | Form 4 | |||
| Versant Ventures VII GP, L.P. | 10% owner | Conversion | 1,393,882 | Form 4 | |||
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Conversion | 4,779,793 | Form 4 | |||
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 1,944,444 | $18.00 | $35M | Form 4 | |
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 8,261 | $26.97 | $223K | Form 4 | |
| Laurent Fischer | Director | Options or other derivatives | Form 4 | ||||
| Jane Henderson | Director | Options or other derivatives | Form 4 | ||||
| William Jl Rieflin | Director | Options or other derivatives | Form 4 | ||||
| Sofia Touami | Chief Business Officer | Options or other derivatives | Form 4 | ||||
| Steven Staben | Chief Scientific Officer | Options or other derivatives | Form 4 | ||||
| Chin Hyok Lee | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Amy Bachrodt | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Aetna Wun Trombley | President and CEO | Options or other derivatives | Form 4 | ||||
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 24,560 | $25.68 | $631K | Form 4 | |
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Buy | 28,379 | $26.11 | $741K | Form 4 | |
| ELI LILLY & Co | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Carolyn R Bertozzi | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Jane Henderson | Director | Became an insider (Form 3) | Form 3 | ||||
| Versant Ventures VII GP, L.P. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Laurent Fischer | Director | Became an insider (Form 3) | Form 3 | ||||
| William Jl Rieflin | Director | Became an insider (Form 3) | Form 3 | ||||
| Sofia Touami | Chief Business Officer | Became an insider (Form 3) | Form 3 | ||||
| Steven Staben | Chief Scientific Officer | Became an insider (Form 3) | Form 3 | ||||
| Chin Hyok Lee | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Amy Bachrodt | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Aetna Wun Trombley | President and CEO | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.